| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |